0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Dendritic Cell Cancer Vaccines Market Size Status and Forecast 2019 to 2025
Published Date: March 2019
|
Report Code: QYRE-Othe-280
Home | Category |Health |Health Conditions
Global Dendritic Cell Cancer Vaccines Market Size Status and Forecast 2019 to 2025

Global Dendritic Cell Cancer Vaccines Market Size Status and Forecast 2019 to 2025

Code: QYRE-Othe-280
Report
March 2019
100 Pages
QYResearch
Region: North America, South America, Europe, Asia Pacific,
Description
Table of Content
Tables & Figures

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
In 2018, the global Dendritic Cell Cancer Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.

The key players covered in this study
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics

Market segment by Type, the product can be split into
CreaVax
Sipuleucel-T (Provenge)
Others

Market segment by Application, split into
Pediatrics
Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 CreaVax
1.4.3 Sipuleucel-T (Provenge)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dendritic Cell Cancer Vaccines Market Size
2.2 Dendritic Cell Cancer Vaccines Growth Trends by Regions
2.2.1 Dendritic Cell Cancer Vaccines Market Size by Regions (2014-2025)
2.2.2 Dendritic Cell Cancer Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dendritic Cell Cancer Vaccines Market Size by Manufacturers
3.1.1 Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Dendritic Cell Cancer Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Dendritic Cell Cancer Vaccines Key Players Head office and Area Served
3.3 Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
3.4 Date of Enter into Dendritic Cell Cancer Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019)
4.2 Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Dendritic Cell Cancer Vaccines Market Size (2014-2019)
5.2 Dendritic Cell Cancer Vaccines Key Players in United States
5.3 United States Dendritic Cell Cancer Vaccines Market Size by Type
5.4 United States Dendritic Cell Cancer Vaccines Market Size by Application

6 Europe
6.1 Europe Dendritic Cell Cancer Vaccines Market Size (2014-2019)
6.2 Dendritic Cell Cancer Vaccines Key Players in Europe
6.3 Europe Dendritic Cell Cancer Vaccines Market Size by Type
6.4 Europe Dendritic Cell Cancer Vaccines Market Size by Application

7 China
7.1 China Dendritic Cell Cancer Vaccines Market Size (2014-2019)
7.2 Dendritic Cell Cancer Vaccines Key Players in China
7.3 China Dendritic Cell Cancer Vaccines Market Size by Type
7.4 China Dendritic Cell Cancer Vaccines Market Size by Application

8 Japan
8.1 Japan Dendritic Cell Cancer Vaccines Market Size (2014-2019)
8.2 Dendritic Cell Cancer Vaccines Key Players in Japan
8.3 Japan Dendritic Cell Cancer Vaccines Market Size by Type
8.4 Japan Dendritic Cell Cancer Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dendritic Cell Cancer Vaccines Market Size (2014-2019)
9.2 Dendritic Cell Cancer Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type
9.4 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application

10 India
10.1 India Dendritic Cell Cancer Vaccines Market Size (2014-2019)
10.2 Dendritic Cell Cancer Vaccines Key Players in India
10.3 India Dendritic Cell Cancer Vaccines Market Size by Type
10.4 India Dendritic Cell Cancer Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Dendritic Cell Cancer Vaccines Market Size (2014-2019)
11.2 Dendritic Cell Cancer Vaccines Key Players in Central & South America
11.3 Central & South America Dendritic Cell Cancer Vaccines Market Size by Type
11.4 Central & South America Dendritic Cell Cancer Vaccines Market Size by Application

12 International Players Profiles
12.1 3M Company
12.1.1 3M Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dendritic Cell Cancer Vaccines Introduction
12.1.4 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.1.5 3M Company Recent Development
12.2 Activarti
12.2.1 Activarti Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dendritic Cell Cancer Vaccines Introduction
12.2.4 Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.2.5 Activarti Recent Development
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dendritic Cell Cancer Vaccines Introduction
12.3.4 Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.3.5 Argos Therapeutics Recent Development
12.4 Batavia Bioservices
12.4.1 Batavia Bioservices Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dendritic Cell Cancer Vaccines Introduction
12.4.4 Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.4.5 Batavia Bioservices Recent Development
12.5 Bellicum Pharmaceuticals
12.5.1 Bellicum Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dendritic Cell Cancer Vaccines Introduction
12.5.4 Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.5.5 Bellicum Pharmaceuticals Recent Development
12.6 Creagene
12.6.1 Creagene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dendritic Cell Cancer Vaccines Introduction
12.6.4 Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.6.5 Creagene Recent Development
12.7 DanDrit Biotech
12.7.1 DanDrit Biotech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dendritic Cell Cancer Vaccines Introduction
12.7.4 DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.7.5 DanDrit Biotech Recent Development
12.8 DCPrime
12.8.1 DCPrime Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dendritic Cell Cancer Vaccines Introduction
12.8.4 DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.8.5 DCPrime Recent Development
12.9 Sanpower Corporation
12.9.1 Sanpower Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dendritic Cell Cancer Vaccines Introduction
12.9.4 Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.9.5 Sanpower Corporation Recent Development
12.10 Elios Therapeutics
12.10.1 Elios Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dendritic Cell Cancer Vaccines Introduction
12.10.4 Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.10.5 Elios Therapeutics Recent Development
12.11 ImmunoCellular Therapeutics
12.12 Immunicum
12.13 Kiromic
12.14 Medigene
12.15 Merck
12.16 Northwest Biotherapeutics
12.17 Glaxo Smith Kline
12.18 Tellaorporation
12.19 Vaxil BioTherapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Dendritic Cell Cancer Vaccines Key Market Segments
Table Key Players Dendritic Cell Cancer Vaccines Covered
Table Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type 2014-2025
Figure CreaVax Figures
Table Key Players of CreaVax
Figure Sipuleucel-T (Provenge) Figures
Table Key Players of Sipuleucel-T (Provenge)
Figure Others Figures
Table Key Players of Others
Table Global Dendritic Cell Cancer Vaccines Market Size Growth by Application 2014-2025 (Million US$)
Figure Pediatrics Case Studies
Figure Adults Case Studies
Figure Dendritic Cell Cancer Vaccines Report Years Considered
Table Global Dendritic Cell Cancer Vaccines Market Size 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2019 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2019
Table Market Top Trends
Table Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers in 2018
Table Global Dendritic Cell Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
Table Date of Enter into Dendritic Cell Cancer Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Type (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2014-2019)
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Revenue Market Share by Application in 2018
Figure United States Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Europe Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure China Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Type (2014-20189) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Japan Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure India Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Table 3M Company Company Details
Table 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019) (Million US$)
Figure 3M Company Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table 3M Company Recent Development
Table Activarti Company Details
Table Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Activarti Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Activarti Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Argos Therapeutics Recent Development
Table Batavia Bioservices Company Details
Table Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Batavia Bioservices Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Batavia Bioservices Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Bellicum Pharmaceuticals Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Creagene Company Details
Table Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Creagene Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Creagene Recent Development
Table DanDrit Biotech Company Details
Table DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DanDrit Biotech Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DanDrit Biotech Recent Development
Table DCPrime Company Details
Table DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DCPrime Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DCPrime Recent Development
Table Sanpower Corporation Company Details
Table Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Sanpower Corporation Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Sanpower Corporation Recent Development
Table Elios Therapeutics Company Details
Table Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Elios Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Elios Therapeutics Recent Development
Table ImmunoCellular Therapeutics Company Details
Table Immunicum Company Details
Table Kiromic Company Details
Table Medigene Company Details
Table Merck Company Details
Table Northwest Biotherapeutics Company Details
Table Glaxo Smith Kline Company Details
Table Tellaorporation Company Details
Table Vaxil BioTherapeutics Company Details
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions in 2025
Figure United States Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product in 2025
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. Isolated DCs loaded with tumor antigen ex vivo and administered as a cellular vaccine are found to induce protective and therapeutic anti-tumor immunity in experimental animals.
Increase in prevalence of cancer, improvement of technology such as drug innovations regarding cancer, upsurge in awareness about cancer and their available therapies in the market, and increase in health care expenditure drive the market.
In 2018, the global Dendritic Cell Cancer Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.

The key players covered in this study
3M Company
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
Tellaorporation
Vaxil BioTherapeutics

Market segment by Type, the product can be split into
CreaVax
Sipuleucel-T (Provenge)
Others

Market segment by Application, split into
Pediatrics
Adults

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Dendritic Cell Cancer Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Dendritic Cell Cancer Vaccines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Read More

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 CreaVax
1.4.3 Sipuleucel-T (Provenge)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccines Market Share by Application (2014-2025)
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Dendritic Cell Cancer Vaccines Market Size
2.2 Dendritic Cell Cancer Vaccines Growth Trends by Regions
2.2.1 Dendritic Cell Cancer Vaccines Market Size by Regions (2014-2025)
2.2.2 Dendritic Cell Cancer Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Dendritic Cell Cancer Vaccines Market Size by Manufacturers
3.1.1 Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019)
3.1.2 Global Dendritic Cell Cancer Vaccines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Dendritic Cell Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Dendritic Cell Cancer Vaccines Key Players Head office and Area Served
3.3 Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
3.4 Date of Enter into Dendritic Cell Cancer Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019)
4.2 Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019)

5 United States
5.1 United States Dendritic Cell Cancer Vaccines Market Size (2014-2019)
5.2 Dendritic Cell Cancer Vaccines Key Players in United States
5.3 United States Dendritic Cell Cancer Vaccines Market Size by Type
5.4 United States Dendritic Cell Cancer Vaccines Market Size by Application

6 Europe
6.1 Europe Dendritic Cell Cancer Vaccines Market Size (2014-2019)
6.2 Dendritic Cell Cancer Vaccines Key Players in Europe
6.3 Europe Dendritic Cell Cancer Vaccines Market Size by Type
6.4 Europe Dendritic Cell Cancer Vaccines Market Size by Application

7 China
7.1 China Dendritic Cell Cancer Vaccines Market Size (2014-2019)
7.2 Dendritic Cell Cancer Vaccines Key Players in China
7.3 China Dendritic Cell Cancer Vaccines Market Size by Type
7.4 China Dendritic Cell Cancer Vaccines Market Size by Application

8 Japan
8.1 Japan Dendritic Cell Cancer Vaccines Market Size (2014-2019)
8.2 Dendritic Cell Cancer Vaccines Key Players in Japan
8.3 Japan Dendritic Cell Cancer Vaccines Market Size by Type
8.4 Japan Dendritic Cell Cancer Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Dendritic Cell Cancer Vaccines Market Size (2014-2019)
9.2 Dendritic Cell Cancer Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type
9.4 Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application

10 India
10.1 India Dendritic Cell Cancer Vaccines Market Size (2014-2019)
10.2 Dendritic Cell Cancer Vaccines Key Players in India
10.3 India Dendritic Cell Cancer Vaccines Market Size by Type
10.4 India Dendritic Cell Cancer Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Dendritic Cell Cancer Vaccines Market Size (2014-2019)
11.2 Dendritic Cell Cancer Vaccines Key Players in Central & South America
11.3 Central & South America Dendritic Cell Cancer Vaccines Market Size by Type
11.4 Central & South America Dendritic Cell Cancer Vaccines Market Size by Application

12 International Players Profiles
12.1 3M Company
12.1.1 3M Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Dendritic Cell Cancer Vaccines Introduction
12.1.4 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.1.5 3M Company Recent Development
12.2 Activarti
12.2.1 Activarti Company Details
12.2.2 Company Description and Business Overview
12.2.3 Dendritic Cell Cancer Vaccines Introduction
12.2.4 Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.2.5 Activarti Recent Development
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Dendritic Cell Cancer Vaccines Introduction
12.3.4 Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.3.5 Argos Therapeutics Recent Development
12.4 Batavia Bioservices
12.4.1 Batavia Bioservices Company Details
12.4.2 Company Description and Business Overview
12.4.3 Dendritic Cell Cancer Vaccines Introduction
12.4.4 Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.4.5 Batavia Bioservices Recent Development
12.5 Bellicum Pharmaceuticals
12.5.1 Bellicum Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Dendritic Cell Cancer Vaccines Introduction
12.5.4 Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.5.5 Bellicum Pharmaceuticals Recent Development
12.6 Creagene
12.6.1 Creagene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Dendritic Cell Cancer Vaccines Introduction
12.6.4 Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.6.5 Creagene Recent Development
12.7 DanDrit Biotech
12.7.1 DanDrit Biotech Company Details
12.7.2 Company Description and Business Overview
12.7.3 Dendritic Cell Cancer Vaccines Introduction
12.7.4 DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.7.5 DanDrit Biotech Recent Development
12.8 DCPrime
12.8.1 DCPrime Company Details
12.8.2 Company Description and Business Overview
12.8.3 Dendritic Cell Cancer Vaccines Introduction
12.8.4 DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.8.5 DCPrime Recent Development
12.9 Sanpower Corporation
12.9.1 Sanpower Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Dendritic Cell Cancer Vaccines Introduction
12.9.4 Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.9.5 Sanpower Corporation Recent Development
12.10 Elios Therapeutics
12.10.1 Elios Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Dendritic Cell Cancer Vaccines Introduction
12.10.4 Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)
12.10.5 Elios Therapeutics Recent Development
12.11 ImmunoCellular Therapeutics
12.12 Immunicum
12.13 Kiromic
12.14 Medigene
12.15 Merck
12.16 Northwest Biotherapeutics
12.17 Glaxo Smith Kline
12.18 Tellaorporation
12.19 Vaxil BioTherapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Read More

List of Tables and Figures

Table Dendritic Cell Cancer Vaccines Key Market Segments
Table Key Players Dendritic Cell Cancer Vaccines Covered
Table Global Dendritic Cell Cancer Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type 2014-2025
Figure CreaVax Figures
Table Key Players of CreaVax
Figure Sipuleucel-T (Provenge) Figures
Table Key Players of Sipuleucel-T (Provenge)
Figure Others Figures
Table Key Players of Others
Table Global Dendritic Cell Cancer Vaccines Market Size Growth by Application 2014-2025 (Million US$)
Figure Pediatrics Case Studies
Figure Adults Case Studies
Figure Dendritic Cell Cancer Vaccines Report Years Considered
Table Global Dendritic Cell Cancer Vaccines Market Size 2014-2025 (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2025 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions 2014-2019 (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2014-2019
Figure Global Dendritic Cell Cancer Vaccines Market Share by Regions 2019
Table Market Top Trends
Table Global Dendritic Cell Cancer Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Share by Manufacturers in 2018
Table Global Dendritic Cell Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Dendritic Cell Cancer Vaccines Product/Solution/Service
Table Date of Enter into Dendritic Cell Cancer Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Type (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Type (2014-2019)
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global Dendritic Cell Cancer Vaccines Market Size Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Market Size Market Share by Application (2014-2019)
Figure Global Dendritic Cell Cancer Vaccines Revenue Market Share by Application in 2018
Figure United States Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table United States Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table United States Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table United States Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Europe Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Europe Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Europe Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure China Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Type (2014-20189) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table China Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table China Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Japan Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Japan Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Japan Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure India Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table India Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table India Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Dendritic Cell Cancer Vaccines Market Share (2018-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Type (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Type (2014-2019)
Table Central & South America Dendritic Cell Cancer Vaccines Market Size by Application (2014-2019) (Million US$)
Table Central & South America Dendritic Cell Cancer Vaccines Market Share by Application (2014-2019)
Table 3M Company Company Details
Table 3M Company Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019) (Million US$)
Figure 3M Company Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table 3M Company Recent Development
Table Activarti Company Details
Table Activarti Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Activarti Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Activarti Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Argos Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Argos Therapeutics Recent Development
Table Batavia Bioservices Company Details
Table Batavia Bioservices Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Batavia Bioservices Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Batavia Bioservices Recent Development
Table Bellicum Pharmaceuticals Company Details
Table Bellicum Pharmaceuticals Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Bellicum Pharmaceuticals Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Bellicum Pharmaceuticals Recent Development
Table Creagene Company Details
Table Creagene Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Creagene Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Creagene Recent Development
Table DanDrit Biotech Company Details
Table DanDrit Biotech Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DanDrit Biotech Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DanDrit Biotech Recent Development
Table DCPrime Company Details
Table DCPrime Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure DCPrime Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table DCPrime Recent Development
Table Sanpower Corporation Company Details
Table Sanpower Corporation Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Sanpower Corporation Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Sanpower Corporation Recent Development
Table Elios Therapeutics Company Details
Table Elios Therapeutics Revenue in Dendritic Cell Cancer Vaccines Business (2014-2019)(Million US$)
Figure Elios Therapeutics Revenue Growth Rate in Dendritic Cell Cancer Vaccines Business (2014-2019)
Table Elios Therapeutics Recent Development
Table ImmunoCellular Therapeutics Company Details
Table Immunicum Company Details
Table Kiromic Company Details
Table Medigene Company Details
Table Merck Company Details
Table Northwest Biotherapeutics Company Details
Table Glaxo Smith Kline Company Details
Table Tellaorporation Company Details
Table Vaxil BioTherapeutics Company Details
Table Global Dendritic Cell Cancer Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size Share by Regions in 2025
Figure United States Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Dendritic Cell Cancer Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Product in 2025
Table Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application (2019-2025)
Figure Global Dendritic Cell Cancer Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows multiple user to access the PDF.

Enterprise License

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

Global Pain Relief Medications Market Size Status and Forecast 2020 2026
Global Pain Relief Medications Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-26E1894
Fri Mar 20 00:00:00 UTC 2020

Add to Cart

Global Migraine Headache Drugs Market Size Status and Forecast 2020 2026
Global Migraine Headache Drugs Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-1A2265
Fri Mar 20 00:00:00 UTC 2020

Add to Cart

Global Type 2 Diabetes Medication Market Size Status and Forecast 2020 2026
Global Type 2 Diabetes Medication Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-23T1848
Fri Mar 20 00:00:00 UTC 2020

Add to Cart

Global Oncolytic Virus Cancer Immunotherapy Market Size Status and Forecast 2020 2026
Global Oncolytic Virus Cancer Immunotherapy Market Size, Status and Forecast 2020-2026

120 Pages
Type: Report
Code: QYRE-Auto-39F1801
Fri Mar 20 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0